Crinetics Pharmaceuticals (CRNX) Earnings Date, Estimates & Call Transcripts → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free crnx Stock Alerts $44.22 +0.78 (+1.80%) (As of 04/23/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 2EstimatedActual EPS (Feb. 28) -$0.90 Missed By -$0.01 Consensus EPS (Feb. 28) -$0.89 Read Call TranscriptListen to Call Get Crinetics Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for CRNX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCRNX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CRNX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchHow to camouflage a factory of 53,000 workers"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio."Get the full story here. Crinetics Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.84)($0.68)($0.76)Q2 20242($0.86)($0.71)($0.79)Q3 20242($0.90)($0.74)($0.82)Q4 20242($0.90)($0.77)($0.84)FY 20248($3.50)($2.90)($3.20)CRNX Earnings Date and InformationCrinetics Pharmaceuticals last issued its quarterly earnings data on February 28th, 2024. The reported ($0.90) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.89) by $0.01. Its quarterly revenue was down 100.0% on a year-over-year basis. Crinetics Pharmaceuticals has generated ($3.70) earnings per share over the last year (($3.70) diluted earnings per share). Earnings for Crinetics Pharmaceuticals are expected to decrease in the coming year, from ($3.34) to ($3.55) per share. Crinetics Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.Read More Crinetics Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/2/2024Estimated)------- 2/28/2024Q4 2023($0.89)($0.90)($0.01)($0.90)$0.20 million- 11/7/2023Q3 2023($0.89)($1.01)($0.12)($1.01)-$0.35 million8/8/2023Q2 2023($0.85)($0.94)($0.09)($0.94)$5.00 million$0.99 million5/4/2023Q1 2023($0.82)($0.85)($0.03)($0.85)$0.63 million$2.68 million2/28/2023Q4 2022($0.82)($0.84)($0.02)($0.84)$0.75 million$0.71 million11/14/2022Q3 2022($0.78)($0.78)-($0.78)$1.00 million$0.46 million Get the Latest News and Ratings for CRNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/12/2022Q2 2022($0.62)($0.81)($0.19)($0.81)$1.80 million$0.44 million5/12/2022Q1 2022($0.56)($0.73)($0.17)($0.73)-$3.13 million3/30/2022Q4 2021($0.57)($0.68)($0.11)($0.68)-$1.08 million11/5/2021Q3 2021($0.72)($0.73)($0.01)($0.73)-- 8/9/2021Q2 2021($0.61)($0.70)($0.09)($0.70)--5/6/2021Q1 2021($0.66)($0.69)($0.03)($0.69)-- Crinetics Pharmaceuticals Earnings - Frequently Asked Questions When is Crinetics Pharmaceuticals's earnings date? Crinetics Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on CRNX's earnings history. Did Crinetics Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Crinetics Pharmaceuticals (NASDAQ:CRNX) missed the analysts' consensus estimate of ($0.89) by $0.01 with a reported earnings per share (EPS) of ($0.90). Learn more on analysts' earnings estimate vs. CRNX's actual earnings. How can I listen to Crinetics Pharmaceuticals's earnings conference call? The conference call for Crinetics Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Crinetics Pharmaceuticals's conference call transcript? The conference call transcript for Crinetics Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Crinetics Pharmaceuticals generate each year? Crinetics Pharmaceuticals (NASDAQ:CRNX) has a recorded annual revenue of $4.01 million. How much profit does Crinetics Pharmaceuticals generate each year? Crinetics Pharmaceuticals (NASDAQ:CRNX) has a recorded net income of -$214.53 million. CRNX has generated -$3.70 earnings per share over the last four quarters. What is Crinetics Pharmaceuticals's EPS forecast for next year? Crinetics Pharmaceuticals's earnings are expected to decrease from ($3.34) per share to ($3.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies: RayzeBio Earnings Avadel Pharmaceuticals Earnings Akero Therapeutics Earnings Icosavax Earnings Bicycle Therapeutics Earnings Aeglea BioTherapeutics Earnings Ionis Pharmaceuticals Earnings ImmunoGen Earnings Roivant Sciences Earnings TransMedics Group Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NASDAQ:CRNX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHow to camouflage a factory of 53,000 workersStansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
